201 related articles for article (PubMed ID: 8361780)
1. The discriminating analysis in the differential diagnosis of monoclonal gammopathies.
Büchi G; Veglio M; Reviglione G; Grosso E; Termine G; Girotto M; Autino R
Pathologica; 1993; 85(1096):175-81. PubMed ID: 8361780
[TBL] [Abstract][Full Text] [Related]
2. Kappa/lambda ratio on peripheral blood lymphocytes and bone marrow plasma cell labeling index in monoclonal gammopathies.
Büchi G; Girotto M; Veglio M; Clerico M; Gario S; Termine G; Autino R
Haematologica; 1990; 75(2):132-6. PubMed ID: 2113507
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow T-cell subsets in patients with monoclonal gammopathies: correlation with clinical stage and disease status.
Corso A; Castelli G; Pagnucco G; Lazzarino M; Bellio L; Klersy C; Bernasconi C
Haematologica; 1997; 82(1):43-6. PubMed ID: 9107081
[TBL] [Abstract][Full Text] [Related]
4. Differentiation of monoclonal gammopathy of undetermined significance and multiple myeloma using flow cytometric characteristics of plasma cells.
Sezer O; Heider U; Zavrski I; Possinger K
Haematologica; 2001 Aug; 86(8):837-43. PubMed ID: 11522540
[TBL] [Abstract][Full Text] [Related]
5. Application of Capillary Electrophoresis in Monoclonal Gammopathies and the Cutoff Value of Monoclonal Protein in Differential Diagnosis of Multiple Myeloma and Other Monoclonal Gammopathies.
Cao F; Zhang R; Xu L; Liu M; Yuan Y
Ann Clin Lab Sci; 2021 May; 51(3):400-407. PubMed ID: 34162571
[TBL] [Abstract][Full Text] [Related]
6. Immunological methods in the diagnosis of monoclonal gammopathies. The prognostic impact of the immunological data.
Baldea L; Cucuianu A; Cristea A
Rom J Intern Med; 1999; 37(3):217-25. PubMed ID: 15532300
[TBL] [Abstract][Full Text] [Related]
7. Usefulness and reproducibility of cytomorphologic evaluations to differentiate myeloma from monoclonal gammopathies of unknown significance.
Millá F; Oriol A; Aguilar J; Aventín A; Ayats R; Alonso E; Domingo A; Feliu E; Florensa L; López A; Pérez-Vila E; Rozman M; Sánchez C; Vallespí T; Woessner S
Am J Clin Pathol; 2001 Jan; 115(1):127-35. PubMed ID: 11190798
[TBL] [Abstract][Full Text] [Related]
8. Immunophenotypic aberrations, DNA content, and cell cycle analysis of plasma cells in patients with myeloma and monoclonal gammopathies.
Lima M; Teixeira Mdos A; Fonseca S; Gonçalves C; Guerra M; Queirós ML; Santos AH; Coutinho A; Pinho L; Marques L; Cunha M; Ribeiro P; Xavier L; Vieira H; Pinto P; Justiça B
Blood Cells Mol Dis; 2000 Dec; 26(6):634-45. PubMed ID: 11358356
[TBL] [Abstract][Full Text] [Related]
9. [Monoclonal gammopathies of undetermined significance].
Ifrah N; Zandecki M
Rev Prat; 2006 Jan; 56(1):18-24. PubMed ID: 16548245
[TBL] [Abstract][Full Text] [Related]
10. A contribution to examination of propidium iodide and annexin V plasma cells indices in multiple myeloma.
Scudla V; Ordeltova M; Bacovsky J; Vytrasova M; Sumna E; Martinek A; Horak P
Neoplasma; 2003; 50(5):363-71. PubMed ID: 14628090
[TBL] [Abstract][Full Text] [Related]
11. [Importance of selected laboratory indicators in the differential diagnosis and monitoring of multiple myeloma].
Maisnar V; Tousková M; Malý J; Krejsek J; Kmonícek M; Kopecký O
Vnitr Lek; 2002 Apr; 48(4):290-7. PubMed ID: 12061177
[TBL] [Abstract][Full Text] [Related]
12. [Role of bone marrow plasma cell kinetics in the differential diagnosis of monoclonal gammopathies].
Pini E; Tassinari D; Gianni L; Fattori P; Sartori S; Pasquini E; Ravaioli A
Recenti Prog Med; 1995 Jun; 86(6):242. PubMed ID: 7624585
[No Abstract] [Full Text] [Related]
13. Neural cell adhesion molecule expression in plasma cells in bone marrow biopsies and aspirates allows discrimination between multiple myeloma, monoclonal gammopathy of uncertain significance and polyclonal plasmacytosis.
Martín P; Santón A; Bellas C
Histopathology; 2004 Apr; 44(4):375-80. PubMed ID: 15049904
[TBL] [Abstract][Full Text] [Related]
14. The significance of soluble CD138 in diagnosis of monoclonal gammopathies.
Maisnar V; Tousková M; Tichý M; Krejsek J; Chrobák L; Voglová J; Malý J
Neoplasma; 2006; 53(1):26-9. PubMed ID: 16416009
[TBL] [Abstract][Full Text] [Related]
15. Characterization of bone marrow T cells in monoclonal gammopathy of undetermined significance, multiple myeloma, and plasma cell leukemia demonstrates increased infiltration by cytotoxic/Th1 T cells demonstrating a squed TCR-Vbeta repertoire.
Pérez-Andres M; Almeida J; Martin-Ayuso M; Moro MJ; Martin-Nuñez G; Galende J; Hernandez J; Mateo G; San Miguel JF; Orfao A; ;
Cancer; 2006 Mar; 106(6):1296-305. PubMed ID: 16475149
[TBL] [Abstract][Full Text] [Related]
16. Immunophenotypic and DNA content characteristics of plasma cells in multiple myeloma and monoclonal gammopathy of undetermined significance.
Almeida J; Orfao A; Mateo G; Ocqueteau M; García-Sanz R; Moro MJ; Hernandez J; Ortega F; Borrego D; Barez A; Mejido M; San Miguel JF
Pathol Biol (Paris); 1999 Feb; 47(2):119-27. PubMed ID: 10192879
[TBL] [Abstract][Full Text] [Related]
17. [Monoclonal gammopathies in a series of 1683 plasma donors].
Tichý M; Rehácek V; Maisnar V; Dominiková K; Palicka V
Cas Lek Cesk; 2004; 143(6):401-4; discussion 404. PubMed ID: 15309868
[TBL] [Abstract][Full Text] [Related]
18. Peripheral blood B cell labeling indices are a measure of disease activity in patients with monoclonal gammopathies.
Witzig TE; Gonchoroff NJ; Katzmann JA; Therneau TM; Kyle RA; Greipp PR
J Clin Oncol; 1988 Jun; 6(6):1041-6. PubMed ID: 3286829
[TBL] [Abstract][Full Text] [Related]
19. [Monoclonal gammopathies--from MGUS to myeloma].
Hess U; Heijnen IA
Ther Umsch; 2004 Feb; 61(2):161-7. PubMed ID: 15018400
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of serum levels of selected biological parameters in monoclonal gammopathy of undetermined significance and multiple myeloma].
Scudla V; Budíková M; Pika T; Minarík J; Zemanová M; Bacovský J; Heincová V;
Vnitr Lek; 2006 Mar; 52(3):232-40. PubMed ID: 16722154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
